By Maki Shiraki, Daniel Leussink
TAKASAKI, Japan (Reuters) -Four decades ago, Hiroko Suzuki’s father threaded the needle of a U.S. trade war by pushing the family auto-parts business into newer niche products. Now, tariffs imposed by the Trump administration are so sweeping they threaten her own attempt to diversify the 78-year-old company into medical devices.
Prime Minister Shigeru Ishiba has called the U.S. tariffs, including 25% on automobiles, a “national crisis” for the world’s fourth-largest economy. Japan’s top trade negotiator, Ryosei Akazawa, headed to Washington on Friday for a third round of talks.
The worry is evident at companies like Kyowa Industrial, a maker of prototype parts and race-car components based in Takasaki, north of Tokyo. Kyowa, which employs 120 people, was among six auto suppliers that told Reuters they were concerned about their ability to withstand the tariff pressure on Japan’s car industry.
“What in the world are we going to do?” Suzuki, Kyowa’s third-generation president, recalled thinking when the tariffs were announced. “This is going to be bad.”
The problems Kyowa and other auto suppliers face illustrate a decades-long shift in Japan, which no longer floods the world with chips and consumer electronics and is reliant on an auto industry threatened by intense Chinese competition. That marks a contrast with the 1980s, when the U.S. slapped trade barriers on a rising Japan and its then-barnstorming exports.
This report, which is based on interviews with a dozen people, including industry executives, bankers and senior government officials, provides a first-hand account of how one firm is grappling with the uncertainty, and details the deepening squeeze on the automotive supply chain at a time of profound disruption.
Kyowa and thousands of other small manufacturers comprise an auto-supply network that has for decades pursued a “monozukuri” (literally, “making things”) approach to production. That culture of incremental improvement and assembly-line efficiency, based on methods developed by Toyota, helped make Japan a juggernaut.
But the shift to battery-powered smart cars has meant software, in which EV makers such as Tesla and China’s BYD excel, has become a bigger selling point.
Kyowa started developing neurosurgery instruments in 2016 after Suzuki, now 65, realised the rise of EVs would eventually hammer demand for engine components. It began selling the instruments in the U.S. last year, only to find that Trump’s tariffs also applied to medical devices.